DMPK and myotonic dystrophy type 1: Current research primarily explores the complex mechanisms of insulin resistance in DM1 from multiple perspectives, including RNA toxicity-induced alternative splicing abnormalities, post-receptor signaling pathway dysfunction, loss of DMPK protein function, and disruptions in inflammation and metabolism.